Theranostics Report 2007-2012

Questions: Discounts, Updates etc.

Pages: 115

Price (Single): £1,499

Price (Departmental): £2,999

Price (Company): £4,999

Publication Date: 2007-01-31

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Key questions remain over theranostics. How can your company secure key successes and ideals in personalized medicine - aiming the right drug at the right person and at the right time. Plus with increased FDA regulation, how can we guarantee that that specific drug is safe for that individual. These issues are not going away, but this report can make it a lot easier for you and your company to address them.

This report delivers to you a clear understanding of the commercial prospects of theranostics. The fusion of drug therapy and diagnostics, with the purpose of optimising efficacy and safety, as well as streamlining the process of drug development offers you and your company clear opportunities. This emerging field is generating interest from the healthcare industry and regulatory bodies, with the associated market expanding continually as the importance of theranostics is recognised.

Theranostic solutions are playing an increasingly important role in pharmaceutical R&D - increasing safety, speeding up clinical development and facilitating regulatory acceptance. Furthermore, theranostics is paving the way towards the long-held goal of personalised medicine, to the benefit of patients and payers. Theranostics has also received encouraging support from regulators such as the FDA. Pharmaceutical, diagnostics and biotechnological companies cannot afford to overlook this rapidly emerging field. So you should be sure you corner your percentage of the market immediately.

Theranostics 2007-2012 examines the market for theranostic solutions critically, through comprehensive primary and secondary research. Importantly, visiongain discusses theranostics in the context of the wider diagnostics market. In addition to consultation with experts in industry, this research involved a detailed study of documents, industrial reports and relevant news. Importantly, visiongain also applied techniques such as financial forecasting and SWOT analyses. The result is a comprehensive market-based report with detailed analysis and informed opinion.

In particular, this report concentrates on the following essential aspects of the theranostics sector:

  • Technologies that drive the theranostics sector
  • Key industrial players in theranostics - including partnerships in that field
  • Forecasts of the global theranostics market from 2007-2012, including forecasts of the molecular diagnostics market and principal market segments within theranostics
  • Drivers and opportunities in the theranostics sector
  • Restraints and threats in the theranostics sector
  • Assessments of relevant business models, technological solutions and associated issues
  • Coverage of future trends in the sector
  • Insight from a survey with experts from industry and academia

Why you should buy this report: 

  • To receive a comprehensive analysis of the prospects for theranostics from 2007-2012
  • To discover predicted revenues, growth rates and other key metrics for theranostic solutions from 2006-2011
  • To receive the views of experts in the theranostics sector
  • To determine the forces that influence the market for theranostics: Competitive characteristics of the market, Drivers, Restraints, Strengths, weaknesses, opportunities and threats
  • To find out where theranostics is heading - both technologically and commercially

Visiongain predicts that all aspects of theranostics will exhibit strong growth in revenues from 2007-2012, with significant investments being made by far-sighted companies in the pharmaceutical, diagnostics and biotechnological sectors. Although still in its early stages of commercial development, theranostics will increasingly gain acceptance from stakeholders in healthcare. Successful participating companies will benefit as a result, gaining early market prominence from high-value products. But which areas of theranostics will that be? Find out today by ordering your executive copy of Theranostics 2007.

Table of Contents

  • List of Tables
  • Table 2.1 Revenue Generation ($bn) by the World Pharmaceutical Industry, 1999-2005
  • Table 4.1 The World Market for In Vitro Diagnostics ($bn) Showing Revenues for Molecular and Theranostic Applications, 2006-2012
  • Table 4.2 Share (%) of the World In Vitro Diagnostics Market Held by Molecular Diagnostics, 2006 & 2012
  • Table 4.3 Share (%) of the World Molecular Diagnostics Market Held by Theranostics, 2006 & 2012
  • Table 4.4 Revenues ($m) and Growth (%) for Components of the World Theranostics Market, 2006-2012
  • Table 4.5 Market Shares and CAGRs for Applications Within the Theranostics Sector, 2006-2012
  • Table 5.1 A SWOT Chart for Theranostic Applications, 2007-2012

  • List of Figures
  • Figure 2.1 The Increasing Average Cost ($m) of NCE Development, 1976-2005
  • Figure 4.1 The World Market for In Vitro Diagnostics ($bn) Showing Revenues for Molecular and Theranostic Applications, 2006-2012
  • Figure 4.2 Share (%) of the World In Vitro Diagnostics Market Held by Molecular Diagnostics, 2006
  • Figure 4.3 Share (%) of the World In Vitro Diagnostics Market Held by Molecular Diagnostics, 2012
  • Figure 4.4 World Revenues ($m) for Theranostic Applications, 2006-2012
  • Figure 4.5 Share (%) of the World Molecular Diagnostics Market Held by Theranostics, 2006
  • Figure 4.6 Share (%) of the World Molecular Diagnostics Market Held by Theranostics, 2012
  • Figure 4.7 Revenues ($bn) from Theranostics Compared With Those of the World In Vitro Diagnostics Market, 2006-2012
  • Figure 4.8 Revenues ($bn) from Theranostics Compared With Those of the World Molecular Diagnostics Market, 2006-2012
  • Figure 4.9 Share (%) of the World In Vitro Diagnostics Market Held by Theranostics, 2006-2012
  • Figure 4.10 Share (%) of the World Molecular Diagnostics Market Held by Theranostics, 2006-2012
  • Figure 4.11 Revenues ($m) for Components of the World Theranostics Market, 2006-2012
  • Figure 4.12 Components of the World Theranostics Market - Lower Revenues ($m) In Detail, 2006-2012
  • Figure 4.13 CAGR Values (%) for Market Segments Within the Theranostics Sector, 2006-2012
  • Figure 4.14 Percentage Share (%) of The World Theranostics Market Held By Component Market Segments, 2006
  • Figure 4.15 Percentage Share (%) of The World Theranostics Market Held By Component Market Segments, 2012
  • Figure 4.16 Theranostics: Revenues ($m) for Cardiovascular Applications, 2006-2012
  • Figure 4.17 Theranostics: Revenues ($m) for Oncological Applications, 2006-2012
  • Figure 4.18 Theranostics: Revenues ($m) for Infection-Based Applications, 2006-2012
  • Figure 4.19 Theranostics: Revenues ($m) for CNS Applications, 2006-2012
  • Figure 4.20 Theranostics: Revenues ($m) for Metabolic Applications, 2006-2012
  • Figure 4.21 Theranostics: Revenues ($m) for Other Applications, 2006-2012
  • Figure 4.22 Theranostics: Revenues ($m) for Toxicological Applications in Clinical Studies, 2006-2012
  • Other users found this report page using the following search terms: Theranostics diagnostics theranostics theranostic market diagnostics vitro fda diagnostic reimbursement applications molecular

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.

    All reports are subject to copyright